Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
National Institute for Health and Clinical Excellence
Record ID 32011000096
English
Authors' recommendations:
Rivaroxaban, within its marketing authorisation, is recommended as an option for the prevention of venous thromboembolism in adults having elective total hip replacement surgery or elective total knee replacement surgery.
Details
Project Status:
Completed
URL for project:
http://www.nice.org.uk/nicemedia/live/12133/43811/43811.pdf
Year Published:
2009
URL for published report:
http://www.nice.org.uk/TA170
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England
MeSH Terms
- Adult
- Anticoagulants
- Arthroplasty, Replacement, Hip
- Morpholines
- Postoperative Complications
- Thiophenes
- Venous Thromboembolism
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.